Status:
COMPLETED
Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
Lead Sponsor:
Alcon Research
Conditions:
Open-Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of thie study is to compare the safety and IOP-lowering efficacy of AL-37807 Ophthalmic Solution 0.05%, 0.1% and 0.2% dosed QD AM to Xalatan dosed QD PM and Vehicle in patients with open-a...
Eligibility Criteria
Inclusion
- Open-angle glaucoma
- ocular hypertension
Exclusion
- \- VA worse than 0.60
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00465621
Start Date
March 1 2007
Last Update
July 29 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Atlanta
Atlanta, Georgia, United States, 30342